OptMed Obtains $200,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    601 Lexington Avenue New York, NY 10022 USA
  • Company Description
    Our lead biosurgical product in development—Devakor, a topical skin adhesive—is a replacement for surgical sutures. OptMed’s therapeutics in development are based on proprietary new indications for a widely used drug to provide targeted relaxation of smooth muscle in the lower urinary tract.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy